Quality Comes First

          

APAC MARKETS

We seek to advance highly specialised and scientifically valuable fields to elevate the standard of healthcare.

Discover more about Menarini Group

For over 30 years, Menarini has been driving research and development to deliver innovative and effective medicines and healthcare solutions for patients affected by serious health conditions.

Gain a single point of entry to all major APAC markets with a direct presence in 13 key markets.

Sharing your partnering idea

Leverage our omni-channel approach to grow your brand across Asia Pacific.

MARKETS

The healthcare sector in Asia Pacific is rapidly growing. As part of the world’s leading Italian biopharmaceutical company, Menarini AP has a strong presence in 13 key markets across the region.

As a partner of choice for numerous global healthcare companies, we engage in the entire pharmaceutical development lifecycle to tap growth opportunities and grow their brand footprint. In doing so, we also support healthcare professionals and patients with quality medical products and technology to raise standards and invigorate lives for tomorrow.

Our APAC Headquarters

A. MENARINI ASIA-PACIFIC HOLDINGS PTE LTD
A. MENARINI ASIA-PACIFIC PRIVATE LIMITED
A. MENARINI SINGAPORE PTE LTD
A. MENARINI BIOMARKERS SINGAPORE PTE LTD

30 Pasir Panjang Road,
Mapletree Business City,
#08-32 Singapore 117440
Tel: +65-6494-7200
Fax: +65-6999-1787

 

2019

2019

  • 2019 - 11 - 07

    Tillotts partners Menarini to extend Asacol® to the People_s Republic of China

    RHEINFELDEN, Switzerland, October, 28th, 2019 – Tillotts Pharma AG ("Tillotts"), part of the Japanese Zeria Group and A. Menarini International Trading (Wuhan) Co. Ltd. ("Menarini"), a member of the Italian A. Menarini Group today announced an agreement for the distribution and marketing of Tillotts Asacol® product range in the People's Republic of China ("China").
  • 2019 - 09 - 11

    MENARINI: ELCIN BARKER ERGUN GROUP CEO

    Florence, 12th September 2019 - The Board of Directors has appointed Mrs. Elcin Barker Ergun as CEO of Menarini Group. "Elcin Barker Ergun is the ideal addition to the Menarini team, in order to continue the agenda of growth in geography and therapeutic areas" commented Eric Cornut, Chairman of Menarini.
  • 2019 - 07 - 22

    Dermatix(R) Unveils New Product Breakthrough for Acne Scarring Solution

    23 July 2019, Kula Lumpur - Dermatix®, a brand of A.Menarini Singapore Pte.Ltd has just launched its new acne scar care, Dermatix® Acne Scar. Formulating with Niacinamide (Vitamin B3), Alpha Hydroxy Acids (AHAs) and antioxidants, it delivers a gentle exfoliation to repair acne scars for an overall more even skin tone. Created by top derma experts in Europe, it is now available in Malaysia -the Asia Pacific's first country in launching the product.
  • 2019 - 04 - 30

    CALECIM® partners Menarini Asia-Pacific to expand reach of its stem cell skin care products in the region

    CALECIM® Cosmeceuticals (CALECIM®), a wholly owned subsidiary of biotechnology company CellResearch Corporation (CRC), has formed a major partnership with A. Menarini Asia-Pacific Holdings Pte. Ltd. (Menarini Asia-Pacific). The multi-year partnership covers sales and marketing of CALECIM® products to six of the largest skincare markets in the region: China, Hong Kong, Thailand, Malaysia, Philippines and Indonesia; expanding CALECIM®'s global reach to markets of over 1.7 billion people.